A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

The drug development process necessitates the comprehensive evaluation of a candidate’s therapeutic benefits alongside its potential risks. Benefit–risk assessments are central to this endeavour, ...

Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK, Dec. 8, ...

The company's Drug Assessment Platform (DAP) leverages digital twin technology to predict drug efficacy, safety, and patient response with unprecedented accuracy, enabling pharmaceutical companies to ...

July 1 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention ...